It is important to point out that currently available Oncomine datasets do not distinguish bone metastases from other potential metastatic sites; therefore we can not explicitly state that HO-1 overexpression was restricted to bone tumors in those samples. The gene discussed is HMOX1; the disease is bone neoplasm.